Corbus Pharmaceuticals Holdings, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 15.80 million shares for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2021-03-15
- Corbus Pharmaceuticals Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2020-03-31 was 17.31M shares, a 32.25% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2019-06-30 was 281.13K shares.
- Corbus Pharmaceuticals Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2019-03-31 was 13.09M shares, a 12.56% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2018-03-31 was 11.63M shares, a 32.15% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 15.80M shares, a 10.88% increase from fiscal 2019.
- Corbus Pharmaceuticals Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2019 was 14.25M shares, a 19.94% increase from fiscal 2018.
- Corbus Pharmaceuticals Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2018 was 11.88M shares, a 30.04% increase from fiscal 2017.
- Corbus Pharmaceuticals Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2017 was 9.13M shares, a 15.63% increase from fiscal 2016.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | 15.80M shares 10-K · filed 2021-03-15 | ||||
| 2020-03-31 | 17.31M shares 10-Q · filed 2020-05-11 | ||||
| 2019-12-31 | 14.25M shares 10-K · filed 2021-03-15 | ||||
| 2019-09-30 | 13.83M shares 10-Q · filed 2019-11-07 | ||||
| 2019-06-30 | 281.13K shares 10-Q/A · filed 2020-08-31 | 317.94K shares 10-Q/A · filed 2020-08-31 | |||
| 2019-03-31 | 13.09M shares 10-Q · filed 2020-05-11 | ||||
| 2018-12-31 | 11.88M shares 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | 11.72M shares 10-Q · filed 2019-11-07 | ||||
| 2018-06-30 | 11.76M shares 10-Q · filed 2018-08-08 | ||||
| 2018-03-31 | 11.63M shares 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | 9.13M shares 10-K · filed 2019-03-12 | ||||
| 2017-09-30 | 9.01M shares 10-Q · filed 2017-11-08 | 9.01M shares 10-Q · filed 2018-11-08 | |||
| 2017-06-30 | 8.99M shares 10-Q · filed 2018-08-08 | ||||
| 2017-03-31 | 8.80M shares 10-Q · filed 2018-05-10 | ||||
| 2016-12-31 | 7.90M shares 10-K · filed 2018-03-12 | ||||
| 2016-09-30 | 7.72M shares 10-Q · filed 2017-11-08 | 7.72M shares 10-Q · filed 2017-11-08 | |||
| 2016-06-30 | 7.33M shares 10-Q · filed 2017-08-09 | ||||
| 2016-03-31 | 7.12M shares 10-Q · filed 2017-05-09 | ||||
| 2015-12-31 | 5.95M shares 10-K · filed 2018-03-12 | ||||
| 2015-09-30 | 5.80M shares 10-Q · filed 2016-11-10 | ||||
| 2015-06-30 | 12.61M shares 10-Q · filed 2016-08-12 | ||||
| 2015-03-31 | 17.35M shares 10-Q · filed 2016-05-13 | ||||
| 2014-12-31 | 17.27M shares 10-K · filed 2016-03-28 | ||||
| 2014-09-30 | 2.04M shares 10-Q · filed 2015-11-10 | 16.06M shares 10-Q · filed 2014-11-13 | |||
| 2014-06-30 | 15.20M shares 10-Q · filed 2015-08-13 | ||||
| 2014-03-31 | 3.07M shares 10-Q · filed 2015-05-13 | ||||
| 2013-12-31 | 2.50M shares 10-K · filed 2015-02-10 | ||||
| 2013-09-30 | 2.04M shares 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |